Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens

Nopporn Apiwattanakul1, Paul G Thomas, Raymond E Kuhn

  • 1Department of Pediatrics, University of Tennessee Health Sciences Center, 50 N. Dunlap St., Memphis, TN, 38103, USA.

Insights

Helminth infections in mice increase susceptibility to fatal pneumonia caused by Streptococcus pneumoniae. Anti-helminthic treatment reversed this increased risk, suggesting a link between parasitic worms and severe pneumococcal disease.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Parasitology

Background:

  • Pneumonia remains a leading cause of childhood mortality globally.
  • Helminth infections are endemic in many developing regions, overlapping with high rates of pneumococcal disease.

Purpose of the Study:

  • To investigate the impact of helminth coinfection on susceptibility to Streptococcus pneumoniae infection.
  • To determine if helminth infection predisposes to severe pneumococcal pneumonia.

Main Methods:

  • Mice were chronically infected with helminths (Taenia crassiceps or Heligmosomoides polygyrus).
  • Infected and control mice were challenged with Streptococcus pneumoniae.
  • Bioluminescent imaging and lung titers were used to assess pneumonia severity.
  • Challenges with influenza virus, Staphylococcus aureus, and Listeria monocytogenes were performed to assess specificity.

Main Results:

  • Helminth-infected mice exhibited a higher rate and severity of fatal pneumonia upon Streptococcus pneumoniae challenge.
  • This increased susceptibility was specific to S. pneumoniae, as other pathogens did not cause increased morbidity.
  • Anti-helminthic treatment in H. polygyrus-infected mice reversed the heightened susceptibility to pneumococcal pneumonia.

Conclusions:

  • Helminth coinfection predisposes mice to fatal pneumococcal pneumonia by enhancing bacterial outgrowth in the lungs and bloodstream.
  • These findings have significant implications for pneumonia prevention and treatment strategies in regions with high helminth and pneumococcal disease prevalence.